新生儿缺氧缺血性脑病的临床治疗研究进展  

Advances in Clinical Treatment of Neonatal Hypoxic Ischemic Encephalopathy

作　　者：邓提虎[1] DENG Tihu(The First Affiliated Hospital of Guangxi University of Science and Technology,Liuzhou 545106,China)

机构地区：[1]广西科技大学第一附属医院,广西柳州545106

出　　处：《中外医学研究》2021年第8期194-196,共3页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：新生儿缺氧缺血性脑病是造成新生儿致残、死亡的重要原因,其发病过程较为复杂,且临床治疗难度大。从现阶段来看,关于新生儿缺氧缺血性脑病的发生机制临床尚无统一定论,且临床治疗该疾病的方案主要有亚低温疗法、纳洛酮或脑活素等药物治疗、单唾液酸神经节苷脂注射液、高压氧疗法等。基于此,文章通过分析新生儿缺氧缺血性脑病的发生机制,并总结上述治疗方案的相关研究,以此为临床提供参考。Neonatal hypoxic ischemic encephalopathy(HIE)is an important cause of neonatal disability and death,and its pathogenesis is relatively complex,and its clinical treatment is difficult.At the present stage,there is no unified conclusion on the pathogenesis of neonatal hypoxic ischemic encephalopathy,and the main clinical treatment options for this disease include hypothermia therapy,drug therapy such as naloxone or encephalon,monsialic acid ganglioside injection,hyperbaric oxygen therapy,etc.Based on this,this paper analyzes the pathogenesis of neonatal hypoxic-ischemic encephalopathy,and summarizes the relevant studies on the above treatment options,so as to provide clinical reference.

关 键 词：新生儿缺氧缺血性脑病 治疗 研究进展 

分 类 号：R742[医药卫生—神经病学与精神病学]